On the Selectivity of Generative Models in Structure-Based Drug Design.

arXiv:2610.24124v1 Announce Type: cross Abstract: Designing small-molecule drugs that selectively bind to a target protein while avoiding unintended interactions with other proteins is essential for reducing side effects that contribute substantially to clinic